These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16904285)

  • 1. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro.
    Dalton CH; Hattersley IJ; Rutter SJ; Chilcott RP
    Toxicol In Vitro; 2006 Dec; 20(8):1532-6. PubMed ID: 16904285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations.
    Vallet V; Cruz C; Licausi J; Bazire A; Lallement G; Boudry I
    Toxicology; 2008 Apr; 246(1):73-82. PubMed ID: 18294748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino)ethyl] methylphosphonothioate) in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Hum Exp Toxicol; 2005 Jul; 24(7):347-52. PubMed ID: 16119248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography tandem mass spectrometry applied to quantitation of the organophosphorus nerve agent VX in microdialysates from blood probes.
    Stubbs SJ; Read RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1253-6. PubMed ID: 20034857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human scalp permeability to the chemical warfare agent VX.
    Rolland P; Bolzinger MA; Cruz C; Briançon S; Josse D
    Toxicol In Vitro; 2011 Dec; 25(8):1974-80. PubMed ID: 21762776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exposure area on nerve agent absorption through skin in vitro.
    Dalton C; Graham S; Jenner J
    Toxicol In Vitro; 2015 Dec; 30(1 Pt B):454-61. PubMed ID: 26391143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted chemical warfare agent VX toxicity to uniformed soldier using parathion in vitro human skin exposure and absorption.
    Wester RM; Tanojo H; Maibach HI; Wester RC
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):149-52. PubMed ID: 11032770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
    Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine.
    Duncan EJ; Brown A; Lundy P; Sawyer TW; Hamilton M; Hill I; Conley JD
    J Appl Toxicol; 2002; 22(3):141-8. PubMed ID: 12015792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a barrier cream against the chemical warfare agent VX using the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davison CM; Blohm KL; Clarkson ED; Hamilton MG
    Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):35-8. PubMed ID: 15943757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
    van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
    Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H; Price ME; Wetherell JR
    J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aqueous dilution on the absorption of the nerve agent VX through skin in vitro.
    Dalton C; Graham S; Jenner J
    Toxicol In Vitro; 2018 Dec; 53():121-125. PubMed ID: 30099087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro percutaneous penetration of organophosphorus compounds using full-thickness and split-thickness pig and human skin.
    Vallet V; Cruz C; Josse D; Bazire A; Lallement G; Boudry I
    Toxicol In Vitro; 2007 Sep; 21(6):1182-90. PubMed ID: 17481849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse (II): effects of some currently used skin decontaminants (RSDL and Fuller's earth) against liquid sulphur mustard and VX exposure.
    Taysse L; Dorandeu F; Daulon S; Foquin A; Perrier N; Lallement G; Breton P
    Hum Exp Toxicol; 2011 Jun; 30(6):491-8. PubMed ID: 20534641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of VX poisoning following percutaneous exposure in the domestic white pig.
    Chilcott RP; Dalton CH; Hill I; Davidson CM; Blohm KL; Hamilton MG
    Hum Exp Toxicol; 2003 May; 22(5):255-61. PubMed ID: 12774888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.